Table 2.
Procedural characteristics and clinical outcome at 12 months.
| Variable | Value |
|---|---|
| Total vascular access sites, n (%) | |
| Crossover | 56 (94.9) |
| Antegrade | 3 (5.1) |
| Rotarex system selection, n (%) | |
| 8F | 48 (81.4) |
| 6F | 11 (18.6) |
| Duration of MATH (minute) | 10.4 ± 5.6 |
| Blood loss (ml) | 86.6 ± 34.8 |
| Blood transfusion case, n (%) | 0 |
| Recanalization techniques, n (%) | |
| MATH-DCB | 50 (84.7) |
| MATH-DCB+bailout stenting | 9 (15.3) |
| TLR at the 12 months | 9 (15.3) |
| Major complications, n (%) | |
| Perforation | 0 |
| Embolization | 3 (5.1) |
| Dissection | 2 (3.4) |
| Thrombosis | 0 |
| Bleeding | 0 |
| False aneurysm | 0 |
| Infection | 0 |
| Major adverse events, n (%) | |
| Death | 2 (3.4) |
| MI | 2 (3.4) |
| Major amputation | 1 (1.7) |
| Renal failure | 0 |
| Stroke | 0 |
| Rutherford classification, n (%) | |
| 0–1 | 17 (28.8) |
| 2–3 | 35 (59.3) |
| 4–6 | 7 (11.9) |
| ABI postoperative | 0.83 ± 0.33 0.71 ± 0.16*** |
| ABI at the 12 months |
MATH, percutaneous mechanical atherectomy plus thrombectomy; DCB, drug-coated balloon; MI, myocardial infarction; TLR, target lesion revascularization; ABI, ankle/brachial index (compared to preoperative ABI); ***P < 0.001.